Camp4 Therapeutics Reports Q2 2026 Financial Results

What Happened
On August 13, 2026, Camp4 Therapeutics Corporation announced its financial results for the quarter ended June 30, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02). The report was signed by President and CEO Josh Mandel‑Brehm.

Key Details

• Filing date: August 13, 2026 (Form 8‑K, Item 2.02).
• Reporting period: quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8‑K.
• Form 8‑K signed by Josh Mandel‑Brehm, President & CEO.

Why It Matters
This 8‑K notifies investors that Camp4 has released its latest quarterly earnings and financial condition information. Investors should review the furnished press release (Exhibit 99.1) and the company’s other SEC filings for the specific revenue, expense, cash position, and any commentary or guidance that could affect valuation or near‑term expectations.